Amphastar Pharmaceuticals (AMPH) Total Debt (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Total Debt of $611.5 million for Q1 2026, up 1.22% year-over-year from $604.1 million in Q1 2025, and little changed quarter-over-quarter from $610.4 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Total Debt (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Total Debt history runs 14 years deep, the most recent figure standing at $611.5 million for Q1 2026.
- In Q1 2026, Total Debt rose 1.22% year-over-year to $611.5 million; the TTM figure through Mar 2026 stood at $611.5 million (up 1.22% YoY), while the FY2025 annual figure was $610.4 million, up 1.42% from the prior year.
- Total Debt for Q1 2026 stood at $611.5 million, roughly flat from $610.4 million in the prior quarter.
- The five-year high for Total Debt was $638.6 million in Q3 2023, with the low at $75.0 million in Q1 2023.
- The 5-year median for Total Debt is $594.4 million (2024), against an average of $443.1 million.
- The sharpest annual moves came in 2023 and 2024: Total Debt surged 743.74% in 2023, then fell 6.57% in 2024.
- Amphastar Pharmaceuticals' Total Debt stood at $75.9 million in 2022, then soared by 677.51% to $590.0 million in 2023, then increased by 2.01% to $601.9 million in 2024, then gained by 1.42% to $610.4 million in 2025, then gained by 0.18% to $611.5 million in 2026.
- Business Quant data shows AMPH's Total Debt at $611.5 million in Q1 2026, $610.4 million in Q4 2025, and $609.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 760.00 Mn |
| 10 | Amphastar Pharmaceuticals | 942.71 Mn | 652.59 Mn | 93.47 Mn | 612.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 612.05 Mn |
| Mar 31, 2026 | 611.47 Mn |
| Dec 31, 2025 | 610.39 Mn |
| Sep 30, 2025 | 609.51 Mn |
| Jun 30, 2025 | 608.65 Mn |
| Mar 31, 2025 | 604.08 Mn |
| Dec 31, 2024 | 601.86 Mn |
| Sep 30, 2024 | 596.70 Mn |
| Jun 30, 2024 | 587.10 Mn |
| Mar 31, 2024 | 594.43 Mn |
| Dec 31, 2023 | 590.02 Mn |
| Sep 30, 2023 | 638.64 Mn |
| Jun 30, 2023 | 501.20 Mn |
| Mar 31, 2023 | 75.04 Mn |
| Dec 31, 2022 | 75.89 Mn |
| Sep 30, 2022 | 75.69 Mn |
| Jun 30, 2022 | 75.93 Mn |
| Mar 31, 2022 | 76.51 Mn |
| Dec 31, 2021 | 76.98 Mn |
| Sep 30, 2021 | 77.81 Mn |